Daniel Myran
Dr. Daniel Myran is a family, public health, and preventative medicine physician and researcher at the University of Ottawa in Ontario. He is known for his research into the real-world effects of psychedelics, particularly focusing on the risks associated with adverse reactions to hallucinogens, as highlighted in a recent study he led that found a significant increase in mortality risk following bad psychedelic trips.
Not in the pool (under ¢1).
Recent news mentions
Daniel Myran is an associate professor at the University of Toronto and a co-author of the study.
Ontario helpline saw increase in gambling-related requests after province opened regulated market, study finds
Canada· 2026-03-02
Daniel Myran is a family physician and ICES scientist who co-authored the study on ADHD prescriptions.
Stimulant prescriptions for ADHD up sharply since 2015, especially among womenCanada· 2025-12-11
Daniel Myran is a researcher at the Bruyère Health Research Institute in Ottawa who studies cannabis-related health issues.
Número de usuários idosos de cannabis está crescendo. E o risco também, dizem especialistas
Brazil· 2025-06-16
Dr. Daniel Myran is a coauthor of the study linking cannabis use to an increased risk of dementia.
Marijuana hospital visits linked to dementia diagnosis within 5 years, study finds
United States· 2025-04-20
Daniel Myran is the study’s senior author and a family physician at Ottawa Hospital.
Dozens of illegal magic mushroom dispensaries operating in major Canadian cities with no guardrails: studyCanada· 2025-04-12
Dr. Daniel Myran is the lead study author who researched the risks associated with bad psychedelic trips.
Psychedelic trips can go bad. That may have serious consequences, study saysUnited States· 2025-03-04